Newstral
Article
Dallas News on 2023-08-16 13:05
Dallas biotech snags $150 million lifeline for gene therapy pipeline
Related news
- Taysha Gene Therapies hauls in a $50 million lifeline for its gene therapy treatmentsDallas News
- Dallas-based biotech firm Taysha drops gene therapy following FDA meetingDallas News
- BSarepta Snags $1 Billion Deal With Roche For Gene Therapybarrons.com
- Biotech firm commercializing Nationwide Children's gene therapy has raised $40Mbizjournals.com
- Krystal Biotech receives approval in Europe for gene therapy treatmentbizjournals.com
- BBiotech Is Lagging. Blame Gene Therapy Stocks, Analysts Say.barrons.com
- Biotech delays U.S. gene therapy launch due to outbreak, FDA discordbizjournals.com
- Clashes over the Future of Gene Therapy and Crispr at the US's Biggest Biotech MeetingWired.com
- The Promise of Brain-Delivered Gene Therapyjdsupra.com
- The Cellular And Gene Therapy Pipeline Predicament: A Health Insurer’s PerspectiveForbes
- Seeing hope: FDA panel considers gene therapy for blindnessWBNS-10TV
- Gene therapy company bringing 200 jobs to Durhamnewsobserver.com
- Gene therapy helps boys with 'Lorenzo's Oil' diseaseChicago Tribune
- Gene therapy for rare blindness comes with $850,000 price tagCNN
- FDA panel endorses gene therapy treatment for leukemiaSun Sentinel
- FDA advisers endorse what could be 1st US gene therapywsfa.com
- HFDA Advisers Endorse What Could Be First U.S. Gene Therapyhamodia.com
- Boston research company bets on UT Southwestern researcher's gene therapyDallas News
- BBluebird Says Gene-Therapy Patient's Cancer Seems Not Treatment-Relatedbarrons.com